Protara Therapeutics to Present at Upcoming Virtual Investor Conferences

Rhea-AI Summary

Protara Therapeutics, Inc. (Nasdaq: TARA) has announced participation in two upcoming virtual investor conferences in December 2020. The events include the Piper Sandler 32nd Annual Virtual Healthcare Conference and the Evercore ISI 3rd Annual HealthCONx Virtual Conference, where Protara will present on December 3, 2020, at 12:10 PM ET. A live webcast of the Evercore presentation will be available on the company's website, and a replay of the Piper fireside chat is currently accessible. Protara is focused on transformative therapies for cancer and rare diseases.

NEW YORK, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced that management will present at two upcoming virtual investor conferences in December:

• Piper Sandler 32nd Annual Virtual Healthcare Conference
• Evercore ISI 3^rd Annual HealthCONx Virtual Conference on Thursday, December 3, 2020 at 12:10pm ET

A webcast of the live Evercore presentation can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. A replay of the pre-recorded Piper fireside chat is currently available on the Company’s website. The webcasts will be archived on the Company’s website for 90 days following the presentation.

About Protara Therapeutics, Inc.

Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy being developed for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver disease. For more information, visit www.protaratx.com.

Company Contact:

Blaine Davis
Protara Therapeutics
Blaine.Davis@protaratx.com
646-844-0337

FAQ

When will Protara Therapeutics present at the investor conferences in December 2020?

Protara Therapeutics will present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference on December 3, 2020, at 12:10 PM ET.

What is the ticker symbol for Protara Therapeutics?

The ticker symbol for Protara Therapeutics is TARA.

Where can I access the webcast for Protara Therapeutics' conference presentation?

The webcast for Protara Therapeutics' conference presentation can be accessed on their website in the Events and Presentations section.

What are the main therapeutic focuses of Protara Therapeutics?

Protara Therapeutics focuses on developing therapies for cancer and rare diseases with significant unmet needs.

Is there a replay available for Protara Therapeutics' fireside chat?

Yes, a replay of the pre-recorded Piper fireside chat is currently available on Protara Therapeutics' website.